13th Congress of the European Hematology Association
Webcasted Presentation


Risk-adapted therapy of acute lymphoblastic leukemia
Dr. N. Gökbuget, Germany    - Biography
English - 2008-06-13
Topic: Acute Lymphoblastic Leukemia
Get EHA-CME credits for this presentation!
Speaker Disclosure
Research Support/P.I.: Amgen, GlaxoSmithKline, HoffmanLaRoche, Medac Schering, Mundipharma, Sanofi Synthelabo
Employee: No relevant conflicts of interest to declare
Consultant: No relevant conflicts of interest to declare
Major Stockholder: No relevant conflicts of interest to declare
Honoraria / Speakers’ Bureau / Expert Testimony: GlaxoSmithKline, Hoffman La Roche, Novartis, Medac, Mundipharma, Bristol Myers Squibb
Scientific Advisory Board: No relevant conflicts of interest to declare
To be announced!

This presentation will be available soon!
Do you want to be notified once this presentation is available? Simply write your email address below and we will contact you as soon as it does.
Email :